NKTR-181

First-in-Class Opioid Analgesic Results for Chronic Back Pain

First-in-Class Opioid Analgesic Results for Chronic Back Pain

Nektar Therapeutics announced positive results from the SUMMIT-07 Phase 3 study of NKTR-181 for the treatment of moderate-to-severe chronic pain.

Sign Up for Free e-Newsletters